Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIHEAL: Peptide Hydrogel for Periodontal Regeneration
NCT07581613Phase 2Not yet recruiting
- Sponsor
- Siddharth Shanbhag
- Start
- Nov 2026
- Primary completion
- Jun 2029
- Countries
- 2
01
Overview
Phase 2, randomised trial of PeriHeal in periodontitis and intrabony periodontal defect (2 arms), sponsored by Siddharth Shanbhag. Primary endpoint: Clinical Attachment Level change at 12 months. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
PeriHeal
03
Conditions
periodontitisintrabony periodontal defect
Beyond the preview
Go deeper on NCT07581613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581613.